However, the market is not there yet, and employees/patients continue to want access to GLP-1 drugs for weight management
As of May 2026, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, with a public comment period closing June 29, 2026
GLP-1s can help: Reduce appetite and slow digestion: GLP-1s mimic a hormone that signals fullness, helping you eat less without feeling deprived
Rangubpit W et al
Chng oxi ha, bo v da khi gc t do gy hi v chm qu trnh lo ha
For best results, consume 1-2 servings daily, with one serving post-exercise